Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations.
Park SJ, Ju S, Goh SH, Yoon BH, Park JL, Kim JH, Lee S, Lee SJ, Kwon Y, Lee W, Park KC, Lee GK, Park SY, Kim S, Kim SY, Han JY, Lee C.
Park SJ, et al. Among authors: park kc, park sy, park jl.
Cancer Res. 2024 May 2;84(9):1491-1503. doi: 10.1158/0008-5472.CAN-23-1551.
Cancer Res. 2024.
PMID: 38607364